Cutaneous Lupus

MIAMI BEACH, Fla. — Janus kinase inhibitors are an incredibly important, new tool that have exemplified both high efficacy and safety, according to a speaker at South Beach Symposium.

Interferon-alpha activity may be used routinely in clinical settings as a biomarker for cutaneous lupus erythematosus and disease flares, according to a study.

Requiring erythema alone for entry into cutaneous lupus erythematosus trials may exclude patients with skin of color and increase health disparities, according to a study.

CLEVELAND — While new treatments for cutaneous lupus are on the horizon, sunscreen remains the best way to offset effects, according to J. Michelle Kahlenberg, MD, PhD.